BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3859365)

  • 1. Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells.
    Hindenburg AA; Taub RN; Grant S; Chang G; Baker MA
    Cancer Res; 1985 Jul; 45(7):3048-52. PubMed ID: 3859365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells.
    Myers-Robfogel MW; Spataro AC
    Cancer Res; 1980 Jun; 40(6):1940-3. PubMed ID: 7371029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
    Fischer PH; Pamukcu R; Bittner G; Willson JK
    Cancer Res; 1984 Aug; 44(8):3355-9. PubMed ID: 6744269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
    Grant S; Bhalla K; Gleyzer M
    Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
    Chen SF; Ruben RL; Dexter DL
    Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The repair of the surface structure of animal cells.
    Buck CA; Warren L
    J Cell Physiol; 1976 Oct; 89(2):187-200. PubMed ID: 972162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
    Holstege A; Keppler D
    J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness.
    Hofer A; Steverding D; Chabes A; Brun R; Thelander L
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6412-6. PubMed ID: 11353848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.
    Seymour JF; Huang P; Plunkett W; Gandhi V
    Clin Cancer Res; 1996 Apr; 2(4):653-8. PubMed ID: 9816215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
    Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
    Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
    Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I; Saito S; Hori K; Suzuki M; Sato H
    Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase activity and cell surface sialic acid turnover in Rous sarcoma virus transformed chick embryo fibroblasts.
    Myers-Robfogel MW; Spataro AC; Bosmann HB; Morgan HR
    Cancer Biochem Biophys; 1981; 5(3):141-6. PubMed ID: 6266645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
    Gandhi V; Xu YZ; Estey E
    Clin Cancer Res; 1998 Jul; 4(7):1719-26. PubMed ID: 9676847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid.
    Loh E; Kufe DW
    Cancer Res; 1981 Sep; 41(9 Pt 1):3419-23. PubMed ID: 7260907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
    Lucas DL; Webster HK; Wright DG
    J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.